Tasulin 0.4 Tablet PR
By Tasulin
Rx
14 Tablet PR in a Strip

Composition
Tamsulosin(0.4mg)

Manufacturer - Ipca Laboratories Ltd
142 AB, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, Maharashtra

Expires on or after
November, 2026

liver
When using Tasulin 0.4 Tablet PR, it is important to be cautious if you have severe liver disease. In such cases, it may be necessary to adjust the dosage of Tasulin 0.4 Tablet PR, so consulting your doctor is advised before starting or adjusting the medication. It is recommended to not take Uriwell 0.4mg Tablet 10's unless prescribed by a healthcare professional. Additionally, regular monitoring of liver function tests is suggested to ensure the medication is well-tolerated and safe for use.

kidney
Tasulin 0.4 Tablet PR is generally safe for patients with kidney disease, without requiring dosage adjustment. However, caution is advised for those with end-stage kidney disease due to limited data. Regular kidney function tests are recommended. Consult your doctor before use.

alcohol
When taking Tasulin 0.4 Tablet PR, be cautious about consuming alcohol as it can lead to increased drowsiness. Avoid combining Uriwell 0.4mg Tablet 10's with alcohol to prevent low blood pressure, dizziness, and drowsiness. Inform your doctor if you drink alcohol.

driving
It may cause dizziness in some users, affecting driving ability.

pregnancy
Information on the safety of using Tasulin 0.4 Tablet PR during pregnancy is not available. It is recommended to consult your doctor before use. This tablet is intended for use in males only, not females.

breastfeeding
Tasulin 0.4 Tablet PR is likely unsafe during breastfeeding, as it may pass into breastmilk and harm the baby. It is not recommended for use in women. This medicine is intended for use in males only.
Habit Forming | No |
Chemical Class | Sulfonamides Derivative |
Therapeutic Class | UROLOGY |
Action Class | - |
₹197.85
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024